RELAPSE PREVENTION TREATMENT FOR LIVER-TRANSPLANT PATIENTS

This paper explores the utility of relapse prevention therapy (RPT) fo r transplant candidates with substance use disorders. Similarities and differences between this population and the general substance abuse p atient population are discussed and suggestions are made for modifying the RPT treatment protocol. Major issues include the source and inten sity of motivation for treatment, the nature of the therapeutic relati onship, the type and severity of psychosocial consequences that may ha ve been experienced as a result of substance use, and the patient's pe rception of the problem (addiction versus liver disease). Recommendati ons are made to provide empathy and support around medical concerns, m otivate them for sobriety, and work to build collaborative relationshi ps between ream members and patients. Patients need to see the RP ther apists as working to help them maintain sobriety and obtain a transpla nt, not as policing their drug use.